SCHEMBL4158192

SCHEMBL4158192

Cc1ccc(-c2cc(C(F)(F)F)ccc2N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.48
MAPT P10636 2/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPBWR1 P48145 1/20 0.44
KIF11 P52732 3/20 0.42
KDM1A O60341 1/20 0.41
NFE2L2 Q16236 1/20 0.40
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CFTR P13569 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA5A P35218 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787150 0.85 KIF11 (0.61) MAPTKIF11ALDH1A1PKMKDM4E
SCHEMBL18586254 0.84 KIF11 (0.44) KIF11ALDH1A1PKMKDM4EHPGD
SCHEMBL19639118 0.84 TSHR (0.50) CYP3A4MAPTRAB9ANPC1CYP1A2
SCHEMBL12493701 0.82 PTGDR2 (0.50) CYP3A4MAPTRAB9ANPC1KIF11
SCHEMBL3792211 0.81 KIF11 (0.52) MAPTRAB9ANPC1NPBWR1KIF11
SCHEMBL16193476 0.81 L3MBTL1 (0.59) MAPTRAB9ASMN1; SMN2KDM4ECFTR
SCHEMBL25011713 0.80 NPBWR1 (0.45) CYP3A4MAPTRAB9ANPC1CYP1A2
SCHEMBL10078969 0.79 NPBWR1 (0.47) CYP3A4MAPTRAB9ANPC1CYP1A2
SCHEMBL10713204 0.78 TDP1 (0.54) CYP3A4MAPTRAB9ANPC1ALDH1A1
SCHEMBL1241668 0.78 L3MBTL1 (0.41) MAPTRAB9AKIF11CFTRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105316-A1 Biphenyl Thiazole Carboxamides BAYER CROPSCIENCE AG (DE) 2009-04-23 US disclosed
US-20090105316-A1 Biphenyl Thiazole Carboxamides BAYER CROPSCIENCE AG (DE) 2009-04-23 US disclosed
US-20090105316-A1 Biphenyl Thiazole Carboxamides BAYER CROPSCIENCE AG (DE) 2009-04-23 US disclosed
EP-1786795-A2 BIPHENYL THIAZOLE CARBOXAMIDES Bayer CropScience AG (DE) 2007-05-23 EP disclosed
WO-2006024389-A2 BIPHENYL THIAZOLE CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2006-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105316-A1 Biphenyl Thiazole Carboxamides MRPL21, CBR3, BRD4 CYP3A4 56/4885MAPT 2171/4885RAB9A 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.